Actively Recruiting
Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial
Led by Maria Sklodowska-Curie National Research Institute of Oncology · Updated on 2026-04-22
366
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Heel Spur Syndrome (HSS), is a pathology characterized by chronic inflammation and degenerative changes that affect approximately 10% of adults. Although many patients respond to conservative care, about 30% experience persistent pain. Low-dose radiation therapy (LDRT) is a well-established European method with proven anti-inflammatory and immunomodulatory effects. The ORHEELS trial aims to assess whether a Polish standard dose of 6 Gy in 6 daily fractions (fx)(5 times/week) is not inferior to the treatment with total dose of 3 Gy / fx 0,5 Gy /fractionated twice weekly. The study is designed to assess the impact of intensity of treatment (daily (5 times / week) versus twice weekly fractionation) on clinical outcomes.
CONDITIONS
Official Title
Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 40 years or older
- Clinically confirmed painful Heel Spur Syndrome (plantar fasciitis) persisting for at least 3 months
- No effect from previous orthopaedic, physical, or analgesic treatments
- General performance status ZUBROD 0-3
- Exclusion of other local conditions
- Patient readiness for follow-up contact
You will not qualify if you...
- Prior radiotherapy for heel spur
- Local use of corticosteroids within 4 weeks before planned radiotherapy
- Previous trauma or surgery to the foot on the same side
- Systemic diseases such as collagen vascular disease
- Pregnancy or breastfeeding
- Lack of written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch
Gliwice, Poland, 44-102
Actively Recruiting
Research Team
I
Iwona Dębosz-Suwińska
CONTACT
M
Mateusz Gajek
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here